| CPC C07K 16/32 (2013.01) [A61K 47/549 (2017.08); A61K 47/6803 (2017.08); A61K 47/68031 (2023.08); A61K 47/68037 (2023.08); A61K 47/6835 (2017.08); A61K 51/04 (2013.01); A61P 35/00 (2018.01); C07H 15/207 (2013.01)] | 15 Claims |
|
1. A compound of Formula (Ia):
![]() or a pharmaceutically acceptable salt thereof, wherein:
each Q is independently an active agent linked to L′ by a heteroatom;
Z′ is absent or a linking group;
L′ is a linking group attached to the SO2 via a heteroatom selected from O, S, and N, and is selected such that cleavage of the bond between L′ and SO2 promotes cleavage of the bond between L′ and Q to release the active agent;
X is —O—, —CRa2—, or —NR′—;
Ar represents aryl, heteroaryl, cycloalkyl, or heterocycloalkyl;
Y′ is —(CRb2)yN(Ra)—, —(CRb2)yO—, or —(CRb2)yS—, positioned such that the N, O, or S atom is attached to TG if y is 1;
X and Y′ are positioned on adjacent atoms of Ar;
TG is a triggering group that, when activated, generates an N, O, or S atom capable of reacting with the SO2 to displace (Q)q-(L′)w and form a 5-6-membered ring including X—SO2 and the intervening atoms of Ar;
q is an integer having a value from 1 to about 20;
w, x, and y are each independently an integer having a value of 0 or 1;
each Ra and R' is independently hydrogen or lower alkyl; and
each Rb is independently hydrogen or lower alkyl; or
two Rb, together with the carbon atom to which they are attached, form a 3-5-membered ring;
provided that when w is 0, q is 1.
|